ArticleBrain and behavior2026
Association of Cognitive Function With Event-Related Potentials and Immune Inflammation in Adolescents With Major Depressive Disorder.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aimed to investigate cognitive function changes in adolescents with major depressive disorder (MDD) and examine their associations with depression severity, event-related potentials (ERP), T lymphocyte subsets, and inflammatory cytokines to identify exploratory clinical and biological correlates for cognitive impairment in this population.
methodsWe enrolled 89 adolescent patients with MDD and 30 healthy controls, matched for age and gender. Cognitive function was assessed using the Montreal Cognitive Assessment Scale (MoCA), depression severity with the Hamilton Depression Scale (HAMD17), and anxiety with the Hamilton Anxiety Scale. ERP were recorded, and blood samples were analyzed for T lymphocyte subsets and inflammatory cytokines.
resultsAdolescents with MDD exhibited significantly lower MoCA scores, indicating cognitive impairment, particularly in attention, delayed recall, and executive function. ERP component analysis showed prolonged latencies and decreased amplitudes in the MDD group. Increased serum concentrations of interleukin-1 beta and interleukin-6, and elevated percentages of CD3+CD4+ and CD3+CD8+ cells were observed in the depressive group, with positive correlations between CD3+ cells and MoCA scores and between CD3+CD8+ cells and HAMD17 scores.
conclusionAdolescents with MDD showed lower cognitive performance, which was associated with depression severity and immune-inflammatory indicators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.